However, despite many research groups have focused on the analysis of possible differential biomarkers among PsA and RA, no studies have been performed considering a direct comparison between PsA with a RF/ACPA seronegative (Abneg) RA cohort [4, 5]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.